PRPO - Precipio to distribute HemeScreen through Fisher Healthcare channel

• Precipio ( NASDAQ: PRPO ) has entered into an agreement with Fisher Healthcare , a part of Thermo Fisher Scientific to distribute its proprietary HemeScreen assays to its customers.
• The Fisher Healthcare channel will enable Precipio to expand access to laboratories across the U.S. for Precipio’s HemeScreen suite of products.

• This partnership is a logical expansion of Precipio’s distribution strategy, the leveraging of industry leading sales channels rather than building its own sales force.

• “The HemeScreen technology excels in these areas and will support the Fisher Healthcare channel in its commitment to serve its customers.” said Keith Meadors, Precipio’s Senior VP of Products.

For further details see: